Thailand to sell generic Viagra drug: officials

September 26, 2012

Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.

The Thai diamond-shaped little blue pill, which resembles the original produced by US pharmaceutical giant , is called "Sidegra" and will be available on prescription across the country on October 1.

Priced at 25 baht (80 US cents) per pill, Thailand's (FDA) said it will be ten times cheaper than full-price Viagra.

"This measure will solve widespread production of by increasing accessibility to the legal version," FDA secretary general Pipat Yingseree said in a statement.

The release said Pfizer had since looked to discount its pills by 30 percent to "cooperate with the government on curbing fake drugs".

"Pfizer is selling at a discount to be able to compete with our Sidegra," said an official at the state-run Government Pharmaceutical Organisation, which is producing the drug.

No one from Pfizer's offices in Thailand was available for comment.

An FDA official said the US company's patent to produce the anti-impotence had expired in Thailand.

Fake sex drugs are openly on sale on street stalls targeting tourists around the red light districts of the Thai capital.

In a raid on a Bangkok warehouse in July, Thai police seized several hundred thousand purported sex enhancement and aphrodisiac pills and a large haul of sex toys, worth an estimated $3.2 million.

Explore further: S. Korea to approve Viagra generics

Related Stories

S. Korea to approve Viagra generics

March 14, 2012
Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

Internet led to global 'explosion' of fake drugs

June 14, 2012
The rapid growth of Internet commerce has led to an explosion of counterfeit drugs sold around the world, with China the biggest source of fake medicines, pharmaceutical experts said Thursday.

US approves India's Ranbaxy to make generic Lipitor

December 1, 2011
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.

China arrests nearly 2,000 in fake drug crackdown

August 6, 2012
(AP) — China's Ministry of Public Security says it has detained nearly 2,000 people in a nationwide crackdown on counterfeit drugs, including some to treat cancer.

Recommended for you

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

November 22, 2017
Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy (DMD), offer long-term benefits for this disease, including longer preservation of muscle strength and ...

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.